ARKEMA (AKE.PA) Stock Fundamental Analysis
Europe - Euronext Paris - EPA:AKE - FR0010313833 - Common Stock
51 EUR
-0.05 (-0.1%)
Overall AKE gets a fundamental rating of 4 out of 10. We evaluated AKE against 75 industry peers in the Chemicals industry. Both the profitability and the financial health of AKE get a neutral evaluation. Nothing too spectacular is happening here. AKE is cheap, but on the other hand it scores bad on growth.
1. Profitability
1.1 Basic Checks
AKE had positive earnings in the past year.
In the past year AKE had a positive cash flow from operations.
AKE had positive earnings in each of the past 5 years.
AKE had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
The Return On Assets of AKE (1.51%) is comparable to the rest of the industry.
The Return On Equity of AKE (2.90%) is comparable to the rest of the industry.
The Return On Invested Capital of AKE (3.44%) is comparable to the rest of the industry.
AKE had an Average Return On Invested Capital over the past 3 years of 5.57%. This is in line with the industry average of 7.13%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.51% | ||
| ROE | 2.9% | ||
| ROIC | 3.44% |
ROA(3y)4.01%
ROA(5y)5.07%
ROE(3y)7.69%
ROE(5y)9.89%
ROIC(3y)5.57%
ROIC(5y)5.74%
1.3 Margins
AKE's Profit Margin of 2.22% is in line compared to the rest of the industry. AKE outperforms 54.67% of its industry peers.
In the last couple of years the Profit Margin of AKE has declined.
AKE's Operating Margin of 6.35% is in line compared to the rest of the industry. AKE outperforms 57.33% of its industry peers.
AKE's Operating Margin has declined in the last couple of years.
With a Gross Margin value of 19.02%, AKE is not doing good in the industry: 73.33% of the companies in the same industry are doing better.
AKE's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 6.35% | ||
| PM (TTM) | 2.22% | ||
| GM | 19.02% |
OM growth 3Y-14.88%
OM growth 5Y-6.39%
PM growth 3Y-36.12%
PM growth 5Y-8.82%
GM growth 3Y-3.36%
GM growth 5Y-1.36%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), AKE is creating some value.
AKE has more shares outstanding than it did 1 year ago.
The number of shares outstanding for AKE has been reduced compared to 5 years ago.
AKE has a worse debt/assets ratio than last year.
2.2 Solvency
An Altman-Z score of 1.86 indicates that AKE is not a great score, but indicates only limited risk for bankruptcy at the moment.
The Altman-Z score of AKE (1.86) is worse than 73.33% of its industry peers.
The Debt to FCF ratio of AKE is 16.70, which is on the high side as it means it would take AKE, 16.70 years of fcf income to pay off all of its debts.
AKE has a Debt to FCF ratio (16.70) which is comparable to the rest of the industry.
A Debt/Equity ratio of 0.50 indicates that AKE is somewhat dependend on debt financing.
AKE has a Debt to Equity ratio (0.50) which is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.5 | ||
| Debt/FCF | 16.7 | ||
| Altman-Z | 1.86 |
ROIC/WACC0.71
WACC4.84%
2.3 Liquidity
AKE has a Current Ratio of 2.73. This indicates that AKE is financially healthy and has no problem in meeting its short term obligations.
Looking at the Current ratio, with a value of 2.73, AKE belongs to the top of the industry, outperforming 82.67% of the companies in the same industry.
AKE has a Quick Ratio of 1.92. This is a normal value and indicates that AKE is financially healthy and should not expect problems in meeting its short term obligations.
AKE has a Quick ratio of 1.92. This is amongst the best in the industry. AKE outperforms 85.33% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.73 | ||
| Quick Ratio | 1.92 |
3. Growth
3.1 Past
The earnings per share for AKE have decreased strongly by -38.40% in the last year.
AKE shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 0.10% yearly.
The Revenue has been growing slightly by 0.32% in the past year.
Measured over the past years, AKE shows a small growth in Revenue. The Revenue has been growing by 1.78% on average per year.
EPS 1Y (TTM)-38.4%
EPS 3Y-11.49%
EPS 5Y0.1%
EPS Q2Q%-54.67%
Revenue 1Y (TTM)0.32%
Revenue growth 3Y0.09%
Revenue growth 5Y1.78%
Sales Q2Q%-8.65%
3.2 Future
Based on estimates for the next years, AKE will show a decrease in Earnings Per Share. The EPS will decrease by -2.13% on average per year.
Based on estimates for the next years, AKE will show a small growth in Revenue. The Revenue will grow by 1.37% on average per year.
EPS Next Y-42.01%
EPS Next 2Y-19.17%
EPS Next 3Y-8.39%
EPS Next 5Y-2.13%
Revenue Next Year-5.26%
Revenue Next 2Y-2.07%
Revenue Next 3Y-0.23%
Revenue Next 5Y1.37%
3.3 Evolution
The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
AKE is valuated reasonably with a Price/Earnings ratio of 9.90.
AKE's Price/Earnings ratio is rather cheap when compared to the industry. AKE is cheaper than 90.67% of the companies in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 26.57, AKE is valued rather cheaply.
A Price/Forward Earnings ratio of 9.51 indicates a reasonable valuation of AKE.
92.00% of the companies in the same industry are more expensive than AKE, based on the Price/Forward Earnings ratio.
AKE's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 24.04.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 9.9 | ||
| Fwd PE | 9.51 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of AKE indicates a rather cheap valuation: AKE is cheaper than 94.67% of the companies listed in the same industry.
Based on the Price/Free Cash Flow ratio, AKE is valued cheaply inside the industry as 82.67% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 17.09 | ||
| EV/EBITDA | 4.42 |
4.3 Compensation for Growth
A cheap valuation may be justified as AKE's earnings are expected to decrease with -8.39% in the coming years.
PEG (NY)N/A
PEG (5Y)101.33
EPS Next 2Y-19.17%
EPS Next 3Y-8.39%
5. Dividend
5.1 Amount
AKE has a Yearly Dividend Yield of 6.85%, which is a nice return.
Compared to an average industry Dividend Yield of 2.58, AKE pays a better dividend. On top of this AKE pays more dividend than 93.33% of the companies listed in the same industry.
AKE's Dividend Yield is rather good when compared to the S&P500 average which is at 1.88.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 6.85% |
5.2 History
On average, the dividend of AKE grows each year by 6.80%, which is quite nice.
Dividend Growth(5Y)6.8%
Div Incr Years4
Div Non Decr Years4
5.3 Sustainability
129.52% of the earnings are spent on dividend by AKE. This is not a sustainable payout ratio.
The Dividend Rate of AKE has been growing, while earnings will be declining. This means the dividend growth is most likely not sustainable.
DP129.52%
EPS Next 2Y-19.17%
EPS Next 3Y-8.39%
EPA:AKE (12/24/2025, 7:00:00 PM)
51
-0.05 (-0.1%)
Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)
Earnings (Next)
Inst Owners61.12%
Inst Owner ChangeN/A
Ins Owners0.58%
Ins Owner ChangeN/A
Market Cap3.88B
Revenue(TTM)9.54B
Net Income(TTM)210.00M
Analysts71.43
Price Target63.94 (25.37%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 6.85% |
Yearly Dividend3.46
Dividend Growth(5Y)6.8%
DP129.52%
Div Incr Years4
Div Non Decr Years4
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-7.64%
Min EPS beat(2)-8.67%
Max EPS beat(2)-6.61%
EPS beat(4)0
Avg EPS beat(4)-8.86%
Min EPS beat(4)-18.44%
Max EPS beat(4)-1.73%
EPS beat(8)3
Avg EPS beat(8)-4.83%
EPS beat(12)7
Avg EPS beat(12)1.09%
EPS beat(16)11
Avg EPS beat(16)10.55%
Revenue beat(2)0
Avg Revenue beat(2)-0.69%
Min Revenue beat(2)-0.92%
Max Revenue beat(2)-0.46%
Revenue beat(4)0
Avg Revenue beat(4)-1.13%
Min Revenue beat(4)-2.56%
Max Revenue beat(4)-0.46%
Revenue beat(8)2
Avg Revenue beat(8)-0.53%
Revenue beat(12)4
Avg Revenue beat(12)-0.93%
Revenue beat(16)8
Avg Revenue beat(16)0.76%
PT rev (1m)-10.29%
PT rev (3m)-18.52%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-28.26%
EPS NY rev (1m)-9.51%
EPS NY rev (3m)-18.53%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-4.74%
Revenue NY rev (1m)-0.44%
Revenue NY rev (3m)-2.33%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 9.9 | ||
| Fwd PE | 9.51 | ||
| P/S | 0.41 | ||
| P/FCF | 17.09 | ||
| P/OCF | 3.82 | ||
| P/B | 0.54 | ||
| P/tB | 1.81 | ||
| EV/EBITDA | 4.42 |
EPS(TTM)5.15
EY10.1%
EPS(NY)5.36
Fwd EY10.52%
FCF(TTM)2.98
FCFY5.85%
OCF(TTM)13.36
OCFY26.19%
SpS124.15
BVpS95.11
TBVpS28.16
PEG (NY)N/A
PEG (5Y)101.33
Graham Number104.98
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.51% | ||
| ROE | 2.9% | ||
| ROCE | 4.88% | ||
| ROIC | 3.44% | ||
| ROICexc | 3.86% | ||
| ROICexgc | 7.22% | ||
| OM | 6.35% | ||
| PM (TTM) | 2.22% | ||
| GM | 19.02% | ||
| FCFM | 2.4% |
ROA(3y)4.01%
ROA(5y)5.07%
ROE(3y)7.69%
ROE(5y)9.89%
ROIC(3y)5.57%
ROIC(5y)5.74%
ROICexc(3y)6.56%
ROICexc(5y)6.98%
ROICexgc(3y)13.06%
ROICexgc(5y)13.27%
ROCE(3y)8.13%
ROCE(5y)8.28%
ROICexgc growth 3Y-19.33%
ROICexgc growth 5Y-9.22%
ROICexc growth 3Y-22.98%
ROICexc growth 5Y-11.22%
OM growth 3Y-14.88%
OM growth 5Y-6.39%
PM growth 3Y-36.12%
PM growth 5Y-8.82%
GM growth 3Y-3.36%
GM growth 5Y-1.36%
F-Score5
Asset Turnover0.68
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.5 | ||
| Debt/FCF | 16.7 | ||
| Debt/EBITDA | 2.56 | ||
| Cap/Depr | 95.75% | ||
| Cap/Sales | 8.36% | ||
| Interest Coverage | 17.14 | ||
| Cash Conversion | 71.35% | ||
| Profit Quality | 108.1% | ||
| Current Ratio | 2.73 | ||
| Quick Ratio | 1.92 | ||
| Altman-Z | 1.86 |
F-Score5
WACC4.84%
ROIC/WACC0.71
Cap/Depr(3y)97.52%
Cap/Depr(5y)93.37%
Cap/Sales(3y)7.14%
Cap/Sales(5y)7.42%
Profit Quality(3y)111.66%
Profit Quality(5y)102.9%
High Growth Momentum
Growth
EPS 1Y (TTM)-38.4%
EPS 3Y-11.49%
EPS 5Y0.1%
EPS Q2Q%-54.67%
EPS Next Y-42.01%
EPS Next 2Y-19.17%
EPS Next 3Y-8.39%
EPS Next 5Y-2.13%
Revenue 1Y (TTM)0.32%
Revenue growth 3Y0.09%
Revenue growth 5Y1.78%
Sales Q2Q%-8.65%
Revenue Next Year-5.26%
Revenue Next 2Y-2.07%
Revenue Next 3Y-0.23%
Revenue Next 5Y1.37%
EBIT growth 1Y-21.16%
EBIT growth 3Y-14.81%
EBIT growth 5Y-4.73%
EBIT Next Year43.04%
EBIT Next 3Y16.99%
EBIT Next 5Y12.34%
FCF growth 1Y-64.53%
FCF growth 3Y33.3%
FCF growth 5Y-10.84%
OCF growth 1Y-26.48%
OCF growth 3Y7%
OCF growth 5Y-2.92%
ARKEMA / AKE.PA FAQ
What is the ChartMill fundamental rating of ARKEMA (AKE.PA) stock?
ChartMill assigns a fundamental rating of 4 / 10 to AKE.PA.
What is the valuation status of ARKEMA (AKE.PA) stock?
ChartMill assigns a valuation rating of 7 / 10 to ARKEMA (AKE.PA). This can be considered as Undervalued.
How profitable is ARKEMA (AKE.PA) stock?
ARKEMA (AKE.PA) has a profitability rating of 4 / 10.
What are the PE and PB ratios of ARKEMA (AKE.PA) stock?
The Price/Earnings (PE) ratio for ARKEMA (AKE.PA) is 9.9 and the Price/Book (PB) ratio is 0.54.
How financially healthy is ARKEMA?
The financial health rating of ARKEMA (AKE.PA) is 5 / 10.